Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI-528 in Adults With Stable Asthma and Exercise-Induced Bronchoconstriction
NCT00590720Phase 2Terminated
- Sponsor
- MedImmune
- Start
- Mar 2008
- Primary completion
- Dec 2008
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of enokizumab in asthma, Exercise-induced bronchoconstriction (EIB), sponsored by MedImmune. Started Mar 2008; status: terminated.
02
Drugs
enokizumab
03
Conditions
asthmaExercise-induced bronchoconstriction (EIB)
Beyond the preview
Go deeper on NCT00590720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00590720.